Crombez Eric (CIK 1653052) reported 13 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-05-15). Recent activity: Sell ABEO (26,143 shares), Buy RARE (34,674 shares), Buy RARE (11,643 shares), Sell RARE (7,029 shares), Sell ABEO (16,284 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-15 | ABEONA THERAPEUTICS INC. (ABEO) | Director | Sell | 26,143 | $144,636 |
| 2026-04-20 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Medical Officer | Buy | 34,674 | $0 |
| 2026-03-03 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Medical Officer | Buy | 11,643 | $0 |
| 2026-03-03 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Medical Officer | Sell | 7,029 | $160,261 |
| 2026-02-02 | ABEONA THERAPEUTICS INC. (ABEO) | Director | Sell | 16,284 | $82,886 |
| 2026-01-27 | ABEONA THERAPEUTICS INC. (ABEO) | Director | Buy | 37,313 | $0 |
| 2025-08-15 | ABEONA THERAPEUTICS INC. (ABEO) | Director | Sell | 4,718 | $32,696 |
| 2025-05-05 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Medical Officer | Sell | 242 | $8,497 |
| 2025-05-05 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Medical Officer | Sell | 520 | $20,405 |
| 2025-03-04 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Medical Officer | Buy | 16,813 | $0 |
| 2025-03-04 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Medical Officer | Buy | 14,971 | $0 |
| 2025-03-04 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Medical Officer | Sell | 8,945 | $376,584 |
| 2025-02-03 | ABEONA THERAPEUTICS INC. (ABEO) | Director | Buy | 36,101 | $0 |
Source: SEC Form 4 filings · as of 2026-05-15